B2M overexpression correlates with malignancy and immune signatures in human gliomas
Abstract Because of the limited treatment strategy of gliomas, the key of diagnosis and treatment is finding new molecular biomarkers. Here, we explored the potential of β2-microglobulin (B2M) to serve as a hopeful candidate for immunotherapy or diagnostic biomarker in gliomas. The genomic profiles,...
Saved in:
Main Authors: | Hao Zhang, Biqi Cui, Yulai Zhou, Xinxing Wang, Wantao Wu, Zeyu Wang, Ziyu Dai, Quan Cheng, Kui Yang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/361963f8f55e4fc9b19b5bf3100bba81 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
by: Zhengang Hu, et al.
Published: (2021) -
Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway
by: Shangfeng Gao, et al.
Published: (2017) -
Identification of Autophagy-Related Prognostic Signature and Analysis of Immune Cell Infiltration in Low-Grade Gliomas
by: Qingli Quan, et al.
Published: (2021) -
Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma
by: Zhang X, et al.
Published: (2021) -
Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma
by: Wenxiu Tian, et al.
Published: (2021)